Selective laser trabeculoplasty: current perspectives

Area of Science:

• Ophthalmology
• Laser Therapy
• Glaucoma Treatment

Background:

• Selective laser trabeculoplasty (SLT) has been utilized for glaucoma management for over ten years.
• The precise mechanism by which SLT reduces intraocular pressure (IOP) is not fully understood.
• Current research explores potential mechanisms including structural alterations, oxidative stress, inflammatory responses, and microbubble formation.

Purpose of the Study:

• To review the current literature on Selective laser trabeculoplasty (SLT).
• To evaluate SLT's mechanism, efficacy, treatment methods, success predictors, adverse events, repeatability, and cost.
• To compare SLT with existing glaucoma treatments.

Main Methods:

• Literature review of existing studies on SLT.
• Analysis of data regarding SLT's effectiveness in lowering IOP.
• Examination of factors influencing SLT success and potential side effects.

Main Results:

• SLT demonstrates comparable IOP-lowering efficacy to argon laser trabeculoplasty and medications for glaucoma and ocular hypertension.
• The IOP-lowering effect of SLT can diminish over time and is not universally effective.
• High pretreatment IOP is the most significant predictor of SLT success, though it benefits various glaucoma types.
• Mild, transient adverse effects like IOP spikes are common but usually resolve.
• Evidence suggests SLT is repeatable and cost-effective.

Conclusions:

• Selective laser trabeculoplasty (SLT) is a viable and cost-effective treatment option for glaucoma and ocular hypertension.
• SLT offers comparable efficacy to traditional methods, with high baseline IOP being a key indicator for successful outcomes.
• Further research into the exact mechanisms of SLT is warranted, alongside continued evaluation of its long-term effectiveness and safety profile.